article thumbnail

How We are Investing Through The Covid Correction

View from Seed

We can stay busy by expending time and effort supporting the existing portfolio, which is the right thing to do and a good use of time. Like most VC’s, we’ve been engrossed in helping our portfolio company founders navigate these challenging times while thinking through how we will approach this market going forward. Wait and see.

Cofounder 194
article thumbnail

How a Seed VC Approaches Pre-Product Startups

View from Seed

Editor’s note: At a recent team meeting at NextView, we looked at the high number of startups we invested in which were pre-product at the time. The question arose: What is a seed VC’s process like when a company is pre-product? A big chunk of our investments at NextView have been made pre-product.

Product 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Got "Founder Fit?" If You Want Venture Capital, You Need It

Up and Running

In as much as a scheduled interview with an angel investor can be, talking with Boris about what it takes to spark the interest of a venture capital firm was a coincidence. ” At present, Version One Ventures portfolio includes startups from all over the United States and Canada.

article thumbnail

Pitch Deck Month: “Is It Working?” (aka the “Traction” Slide)

View from Seed

Seed stage VCs are realistic about how much traction a very raw company might have. At NextView we invest across the spectrum of seed stage companies so roughly 1/3rd of the companies we invest in are pre-product, roughly 1/3rd are post-product but pre-revenue, and perhaps 1/3rd have some very early revenue.

article thumbnail

Startup Data: 4 Strategies Changing the Speed & Size of Your Series A

View from Seed

Once a startup has raised seed capital, plenty of theories and advice exist on how to successfully raise a Series A. Recently, we looked at our own portfolio at NextView Ventures to dig a little deeper on how startups actually raise that next round of financing. in our portfolio. The mean Series A size was $5.2M.

Syndicate 333
article thumbnail

The Future of Health: How We Think About Investing in Healthier Living for Everyday People

View from Seed

It’s a world that doesn’t fit our seed-focused model and fund strategy. Outside of life-sciences, we’ve noticed something interesting emerging: There is a huge dearth of seed capital for health care services and software-driven health-tech companies. 2) Direct-to-Consumer Health Products.

Vertical 120
article thumbnail

Why We Invested in Marlo

View from Seed

Stuck in a meeting which wasn’t productive. The service trends these Net Meeting Scores over time, benchmarking meetings to other people’s, teams’, and companies’, while also providing actionable recommendations that can result in real change & improvement in productivity. Meetings can suck. I know that you’ve been there.